Chemoinformaics analysis of 4-Hydroxy-beta-ionol
| Molecular Weight | 210.317 | nRot | 2 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 7 |
| Exact Molecular Weight | 210.162 | nRing | 1 |
| Solubility: LogS | -2.78 | nHRing | 0 |
| Solubility: LogP | 1.867 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 37.9834 |
| nHD | 2 | BPOL | 22.0706 |
| QED | 0.735 |
| Synth | 3.842 |
| Natural Product Likeliness | 2.843 |
| NR-PPAR-gamma | 0.777 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.363 |
| HIA | 0.007 |
| CACO-2 | -4.359 |
| MDCK | 0.0000199 |
| BBB | 0.628 |
| PPB | 0.628441 |
| VDSS | 1.026 |
| FU | 0.45336 |
| CYP1A2-inh | 0.097 |
| CYP1A2-sub | 0.702 |
| CYP2c19-inh | 0.073 |
| CYP2c19-sub | 0.856 |
| CYP2c9-inh | 0.018 |
| CYP2c9-sub | 0.938 |
| CYP2d6-inh | 0.263 |
| CYP2d6-sub | 0.861 |
| CYP3a4-inh | 0.022 |
| CYP3a4-sub | 0.312 |
| CL | 6.391 |
| T12 | 0.63 |
| hERG | 0.008 |
| Ames | 0.058 |
| ROA | 0.124 |
| SkinSen | 0.095 |
| Carcinogencity | 0.082 |
| EI | 0.128 |
| Respiratory | 0.789 |
| NR-Aromatase | 0.077 |
| Antiviral | Yes |
| Prediction | 0.777811 |